Fadi-Luc Jaber

Fadi-Luc Jaber is a Senior Scientist in Analytical Development at Ultragenyx Pharmaceutical Inc. since July 2022, previously serving as a Faculty Research Associate at Albert Einstein College of Medicine from June 2018 to July 2022. During tenure at Albert Einstein, Fadi-Luc Jaber demonstrated significant advancements in liver disease research, including the development of new in vivo models, enhancement of cell transplantation outcomes, and creation of methods to improve hepatocyte viability for therapeutic applications. Fadi-Luc Jaber's earlier experience includes a Postdoctoral Research Fellowship at the same institution from 2013 to March 2018, where several contributions to cell therapy and liver disease treatments were made. Fadi-Luc Jaber holds a Ph.D. in Oral Biology and Neuroscience from The Ohio State University and degrees from the University of Birmingham and the American University of Beirut, alongside extensive mentorship and publication accomplishments throughout the academic career.